FDA approves landmark pancreatic cancer drug that's shown to improve survival
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases. (Image credit: Manuel Balce Ceneta)
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.npr.org — the content belongs to NPR.
